APA (7th ed.) Citation

Morel, O., El Ghannudi, S., Hess, S., Reydel, A., Crimizade, U., Jesel, L., . . . Ohlmann, P. (2012). The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight. Thrombosis and haemostasis, 108(2), 338. https://doi.org/10.1160/TH11-12-0876

Chicago Style (17th ed.) Citation

Morel, Olivier, et al. "The Extent of P2Y12 Inhibition by Clopidogrel in Diabetes Mellitus Patients with Acute Coronary Syndrome Is Not Related to Glycaemic Control: Roles of White Blood Cell Count and Body Weight." Thrombosis and Haemostasis 108, no. 2 (2012): 338. https://doi.org/10.1160/TH11-12-0876.

MLA (9th ed.) Citation

Morel, Olivier, et al. "The Extent of P2Y12 Inhibition by Clopidogrel in Diabetes Mellitus Patients with Acute Coronary Syndrome Is Not Related to Glycaemic Control: Roles of White Blood Cell Count and Body Weight." Thrombosis and Haemostasis, vol. 108, no. 2, 2012, p. 338, https://doi.org/10.1160/TH11-12-0876.